Pages that link to "Q34963070"

The following pages link to Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis (Q34963070):

Displaying 31 items.

• Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets (Q33375406) (← links)
• Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome (Q33604935) (← links)
• Molecular markers of preterm labor in the choriodecidua (Q33782237) (← links)
• Maternal and fetal alternative complement pathway activation in early severe preeclampsia (Q33795404) (← links)
• Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications (Q33976312) (← links)
• Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease (Q35201052) (← links)
• Antiphospholipid syndrome infectious origin (Q35680777) (← links)
• Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway (Q35786658) (← links)
• Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies (Q36013878) (← links)
• Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection (Q36221493) (← links)
• Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products (Q36351625) (← links)
• Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies (Q36470411) (← links)
• Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia (Q36618406) (← links)
• Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin (Q36754151) (← links)
• Is there a microangiopathic antiphospholipid syndrome? (Q36759849) (← links)
• Role of complement in antiphospholipid antibody-mediated thrombosis (Q36832526) (← links)
• Complement activation fragment Bb in early pregnancy and spontaneous preterm birth (Q36980611) (← links)
• New targeted therapies for treatment of thrombosis in antiphospholipid syndrome (Q36998932) (← links)
• Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons (Q37154879) (← links)
• C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies (Q37581827) (← links)
• The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia (Q37607698) (← links)
• Early Elevations of the Complement Activation Fragment C3a and Adverse Pregnancy Outcomes (Q37607702) (← links)
• Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage (Q37704593) (← links)
• Complement and the antiphospholipid syndrome (Q37897848) (← links)
• Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop? (Q38089684) (← links)
• Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals. (Q38718092) (← links)
• Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy (Q44641118) (← links)
• Anti-fibrillin-1 autoantibodies in normal pregnancy and recurrent pregnancy loss (Q51541747) (← links)
• Obstetric antiphospholipid syndrome (Q58551653) (← links)
• Purpura fulminans-like lesions in antiphospholipid syndrome with endothelial C3 deposition (Q58570527) (← links)
• Pathogenic mechanisms of the anti-phospholipid antibodies (Q84601562) (← links)